Clinical Trials Browser

Available × INDUSTRY × Neoplasms × Clear all

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT02632994 2025-09-29

Master Rollover Protocol for Continued Safety Assessment of Study Drug

Available

Tumor-Agnostic

Neoplasms

NCT06980506 2025-05-22

MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Available

Tumor-Agnostic

Neoplasms

NCT06980519 2025-05-22

MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Available

Tumor-Agnostic

Neoplasms

NCT05572970 2025-04-30

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Available

Tumor-Agnostic

Neoplasms

NCT04853602 2024-08-12

IFx-Hu2.0 Expanded Access Program

Available

Dermatologic

Melanoma, Neoplasms, Carcinoma, Merkel Cell

Clinical Trials

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Master Rollover Protocol for Continued Safety Assessment of Study Drug

MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

IFx-Hu2.0 Expanded Access Program